生命科学资讯

GSK pays $950M in cash for Canadian biotech and its Winrevair-like blood pressure drug

BreezeBio banks $60M to make more precise genetic medicines

GSK to buy pulmonary hypertension biotech 35Pharma for $950M

Illumina Genome Push Raises Questions On Growth, Adoption And Valuation - simplywall.st

Cytiva expands Fast Trak™ process development and validation services facility in India - BioSpectrum India

Parasitology Market Is Going to Boom | Thermo Fisher Scientific • Merck KGaA • Abbott Laboratories - openPR.com

Assessing Illumina (ILMN) Valuation After Recent Share Price Rebound And Longer Term Volatility - Yahoo Finance

Assessing Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Pullback - simplywall.st

After 230% deal size explosion, China is no longer the 'bargain basement' for biopharma licensing: analyst

Werewolf weighs sale or merger as cash reserves whimper

Debbie Dingell makes transaction in Waters Corporation stocks from her brokerage account - Investing.com Canada

HHS commits up to $144M to study anti-aging approaches via ARPA-H

Novo Nordisk to slash Wegovy list price in half in 2027

Illumina launches TruPath Genome, setting a new standard in genomic insight - Investing News Network

Industry groups lay legal groundwork against pricing demos

Roche halts development of satralizumab for DMD bone health - Muscular Dystrophy News

Evinova reels in AI clinical development deals with Astellas and AstraZeneca

FDA freezes enrollment in MacroGenics cancer trial after patient death

Harbour ships CTLA-4 asset to form new biotech in $1.1B biobucks deal

Agilent Technologies, Inc. (A) Sparks Confidence With Latest Approvals - Finviz